Wyss Center has received the CE mark for Epios Cloud, its web-based brain data visualisation software that enables long-term brain monitoring aimed towards personalised treatment.

The software, which is marked Class I medical device, is an application to store, process and review neural signals, including ultra-long-term data, online.

It is designed to display and review electroencephalogram (EEG) recordings made by EEG devices using scalp and sub-scalp electrodes, heart rate and accelerometer measurements over months and years.

Through a web browser, Epios Cloud allows clinicians to access patient data anywhere and anytime.

The software also has the flexibility to connect to brain and other bio-signal recording devices over the web.

Multiple long-term data sources from Epios Cloud allow clinicians to develop bespoke analytics to support personalised clinical decision making.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Home-based monitoring of brain activity using Epios during everyday life in epilepsy patients will help clinicians to characterise the type and number of seizures.

It also helps in improving diagnosis and clinical workflow for pre-surgical planning, as well as developing personalised treatment plans.

Wyss Center neuroscientist Aleksander Sobolewski said: “We developed Epios Cloud as we needed software that would track not only when seizures occur but also the biosignals linked to epilepsy events.

“It gives us a glimpse of what is really going on in the brain during everyday life. In the future, additional data streams could easily be integrated into the platform to support other clinical applications.

“Importantly, centralised data storage will allow a fundamental change in automated analysis of neural data, allowing artificial intelligence algorithms to learn on an ever-growing global data lake – the development of which is already underway.”